Skip to main navigation Skip to search Skip to main content

Texas Tech University Health Sciences Center Researchers Update Current Study Findings on Glioblastomas (Metformin Reduces Viability and Inhibits the Immunoinflammatory Profile of Human Glioblastoma Multiforme Cells)

Press/Media: Research

PeriodJul 8 2024

Media coverage

1

Media coverage

  • TitleTexas Tech University Health Sciences Center Researchers Update Current Study Findings on Glioblastomas (Metformin Reduces Viability and Inhibits the Immunoinflammatory Profile of Human Glioblastoma Multiforme Cells)
    Media name/outletNewsRx Drug Daily
    Country/TerritoryUnited States
    Date7/8/24
    PersonsJorge Cervantes Gonzalez
View all 1
View less

Related content